Number of items: 5.
Factors influencing delays in patient access to new medicines in Canada: a retrospective study of reimbursement processes in public drug plans. (2019)
Mir-Saeed Shayegan Salek,
Sarah Lussier Hoskyn,
Jeffrey Johns,
Nicola Allen
and
Chander Sehgal
Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications. (2019)
Mir-Saeed Shayegan Salek,
Sarah Lussier Hoskyn,
Jeffrey Johns,
Nicola Allen
and
Chander Sehgal
A comparison of reimbursement recommendations by European HTA agencies : Is there opportunity for further alignment? (2017)
Nicola Allen,
Lawrence Liberti,
Stuart R. Walker
and
Sam Salek
Health Technology Assessment (HTA) Case Studies : Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland. (2017)
Nicola Allen,
Stuart R Walker,
Lawrence Liberti
and
Sam Salek
picture_as_pdf
Evaluating alignment between Canadian Common Drug Review reimbursement recommendations and provincial drug plan listing decisions : an exploratory study. (2016)
Nicola Allen,
Stuart R Walker,
Lawrence Liberti,
Chander Sehgal
and
M Sam Salek
This list was generated on Wed Apr 15 01:58:51 2026 BST.